Market Overview

Jim Cramer Gives His Opinion On BioTelemetry And Enterprise Products Partners

Related BEAT
Benzinga's Daily Biotech Pulse: FDA Panel Nod For Akcea, Synergy's Revenue Miss, FDA Warns E-Liquid Makers Again
Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results
Related EPD
Enterprise & Energy Transfer To Restart Old Ocean Pipeline
Earnings Scheduled For April 30, 2018
Dividend Sensei's Portfolio Update 35: If You Want To Get Rich, Follow The Data (Seeking Alpha)

On CNBC's "Mad Money", Jim Cramer said he would hold a long position in BioTelemetry, Inc. (NASDAQ: BEAT).

Cramer also likes Enterprise Products Partners L.P. (NYSE: EPD), but he thinks the whole group is stuck because of the Energy Transfer Partners LP (NYSE: ETP). He added that Enterprise Products Partners is the real deal and he would stay long.

Posted-In: CNBC Mad Money Jim CramerMedia


Related Articles (BEAT + EPD)

View Comments and Join the Discussion!